Brief: Takeda Pharmaceutical Co Ltd Reports Stake Of 5.4% In Phathom Pharmaceuticals Inc As Of March 28
01/04/2024 11:25
April 1 (Reuters) - Takeda Pharmaceutical Co Ltd
4502.T :
* TAKEDA PHARMACEUTICAL CO LTD REPORTS STAKE OF 5.4% IN
PHATHOM
PHARMACEUTICALS INC AS OF MARCH 28 VERSUS. 6.6% AS OF JAN 24 -
SEC FILING
Source text for Eikon: ID:n0001395064-24-000023
Further company coverage: 4502.T
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Phathom Pharmaceuticals
See all newsBrief: Phathom Pharma Provides Update On Litigation Filed By BDR Pharma Against FDA
Phathom Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Phathom Pharmaceuticals Q2 revenue beats on Voquezna prescription growth
Brief: Phathom Pharmaceuticals Q2 Net Income USD -17.582 Million
Phathom Pharmaceuticals Q1 revenue more than doubles, beats estimates